Stem Cells for Drug Discovery (StemBANCC)
Owner/Developer: Innovative Medicines Initiative (IMI)
| Country: | Switzerland |
|---|---|
| Languages: | English |
| Url: | http://stembancc.org/ |
| Contact: | http://stembancc.org/index.php?option=com_contact&view=contact&id=1&Itemid=108 |
| Description: |
StemBANCC is a large-scale, 5 year academic-industry partnership in the area of stem cell research. It brings a consortium of 35 partners together who share their experience and collaborate in 12 work packages. It is a collaborative project between pharmaceutical companies, research institutions and small and medium enterprises (SMEs) to exploit the rich expertise across sectors and enhance knowledge transfer between academia and industry for patient benefit. StemBANCC aims to provide well characterised patient derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable bio-bank. StemBANCC also aims to demonstrate proof of concept for the utility of induced pluripotent stem cells in drug discovery for hard-to-treat disorders. |
| Category: | Research Program/Project/Grant |
| Channel: | Website |
| Audience: | Researchers |
| User access: | Open access |
| Updating frequency: | Frequently updated |
| Relevance: | Replacement - Reduction |
| Purpose: | Method development |
| Technology/Tools: | Alternative test methods (in vitro) - Stem cells |
Did you find what you were looking for?
Yes, I found it! No, I did not!Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.